Digital health vendor viability is now a 2027 contract term
Capital is concentrating into a few AI-native platforms while M&A stays flat and the IPO window stays shut, leaving health systems exposed to mid-contract failure in scheduling, monitoring and virtual care.
For most of the past decade, digital health vendor viability was a diligence checkbox that procurement skimmed and clinical sponsors ignored. That is no longer defensible. Rock Health's Q3 2026 Market Update, published October 9, shows U.S. digital health startups raised $3.7B across 114 deals in the quarter and $11.1B year to date, but the money is pooling in a shrinking set of companies while the exits that used to rescue the rest have gone quiet.
Rock Health Q3 2026 Market Update
| Value ($M) | Average deal size |
|---|---|
| 2024 | $20.6M |
| 2025 | $29.5M |
| 2026 YTD | $31M |
The funding barbell behind the risk
The headline numbers look healthy. Year-to-date funding of $11.1B across 358 deals puts 2026 on pace to clear $14.8B, ahead of 2025. H1 2026 alone brought in $7.4B across 244 deals, up from $6.4B across 245 deals in H1 2025. Deal count is flat while dollars rise, which is the definition of concentration.
Average deal size tells the same story: $31.0M year to date in 2026, up from $29.5M in 2025 and $20.6M in 2024. In Q1 2026, 12 large rounds absorbed close to 60% of all capital deployed. Through H1, rounds of $100M or more took 45% of the total. Fierce Healthcare's fundraising tracker shows the barbell in real time, with a $120M Series B for virtual care storefront General Medicine, led by a16z with Mercy Health participating, sitting alongside $7M to $38M rounds for narrower point solutions.
The companies on the thin end of that barbell are often the ones already embedded in health system workflows. They raised in the pilot era, scaled headcount against a growth thesis, and are now competing for capital against AI-native platforms that investors believe can absorb multiple point solutions at once.
A vendor failure in scheduling, remote monitoring or virtual behavioral health is a clinical continuity event, not a procurement inconvenience.
Why the exit window matters to a hospital CIO
Exits are the pressure valve. When a struggling vendor gets acquired, contracts usually survive, support continues and the transition is managed. That valve is closing. Rock Health counted 45 M&A deals in Q3 and 164 year to date, down from 172 through the same point in 2025. No digital health company has gone public since HeartFlow in August 2025.
The underlying math is stark. More than 3,200 venture-backed digital health companies have raised $2M or more since 2011. Most will never be acquired, and none can list right now. Some portion of that cohort will run out of runway in 2027 without a buyer or a bridge.
That outcome lands on provider organizations, not just investors. A vendor failure in patient scheduling, remote patient monitoring or virtual behavioral health is a clinical continuity event. Patients lose access to a care channel, data stops flowing into the EHR, and the fallback is manual work that staffing models do not cover.
The contract terms that actually protect continuity
Standard SaaS boilerplate assumes a solvent counterparty. Renewal season for 2027 is the moment to assume otherwise. Five terms do most of the work.
First, annual financial-health attestations: a contractual obligation to disclose cash runway, most recent raise and any material change in funding status, with notice triggers if runway drops below a defined threshold. Second, source-code and configuration escrow that includes integration logic and deployment settings, not just a code drop nobody can compile. Third, guaranteed data export in a usable, documented format on a defined timeline, specified at signing rather than negotiated during a crisis. Fourth, minimum transition-services windows, typically 90 to 180 days of continued operation at contracted rates after termination, including bankruptcy-related termination. Fifth, step-in or assignment rights that keep the contract enforceable through an acquisition or asset sale.
None of these are exotic. They are standard in enterprise outsourcing and largely absent from digital health agreements signed between 2019 and 2023.
Consolidation is now the buyer's move, not just the market's
Rock Health's read on the demand side is that enterprises have moved off point-solution experimentation toward architecture, workflow design and consolidation. Implementation, not features, is the moat. That shift gives health systems leverage and a concrete action item ahead of renewals.
Mapping overlapping point tools - three remote monitoring contracts across service lines, two patient messaging vendors, a standalone scheduling layer the EHR can now cover - and collapsing them before renewal reduces both spend and exposure. Fewer vendors means fewer counterparties whose balance sheets you have to underwrite, and larger committed volume with the survivors improves the terms you can demand.
The uncomfortable corollary is that consolidating toward the best-capitalized platforms raises concentration risk of a different kind. The answer is not to avoid consolidation but to pair it with portability: if the data and configuration can leave, the platform relationship stays a commercial decision rather than a hostage situation.
